Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
FIGURE: 1 / 14
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
ACACA and ACACB encode acetyl CoA carboxylase alpha and beta, the rate limiting enzymes that convert acetyl CoA to malonyl CoA for de novo fatty acid synthesis and regulation of fatty acid oxidation. ACACA is primarily cytosolic in lipogenic tissues such as liver and adipose, supporting fatty acid and triglyceride production, while ACACB is enriched in oxidative tissues such as heart and skeletal muscle, producing malonyl CoA near mitochondria to inhibit fatty acid entry via CPT1 and thereby modulate beta oxidation. Both enzymes are large biotin dependent carboxylases with biotin carboxylase, carboxyl transferase, and biotin carrier domains, and they are tightly controlled by phosphorylation through AMPK, by allosteric activation from citrate, by feedback from long chain acyl CoA species, and by transcriptional programs governed by SREBP1 and ChREBP. Genetic variation and dysregulation of ACACA and ACACB influence metabolic disorders including obesity, type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular disease. Pharmacologic ACC inhibitors decrease malonyl CoA levels, reduce lipogenesis, and increase fatty acid oxidation, and are being developed for metabolic and liver indications. Detection and study use enzyme activity assays, metabolite profiling, immunoblotting, and CRISPR or RNA interference approaches.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: ACAC; Acaca; ACACB-1; ACC-a; ACC-alpha; ACC-B; ACC-beta; ACC1; ACC2; ACCA; acetyl-CoA carboxylase (EC 6.4.1.2); acetyl-CoA carboxylase 265; acetyl-coenzyme A carboxylase (EC 6.4.1.2); acetyl-Coenzyme A carboxylase 2; acetyl-Coenzyme A carboxylase alpha; acetyl-Coenzyme A carboxylase beta; unnamed protein product
Gene Aliases: A530025K05Rik; ACAC; Acac1; ACACAD; ACACalpha; ACACbeta; ACC; ACC-beta; ACC1; ACC2; ACCA; ACCalpha; ACCB; ACCbeta; Gm738; hACC1; HACC275
UniProt ID: (Human) Q13085, (Human) O00763, (Mouse) Q5SWU9, (Rat) P11497, (Mouse) E9Q4Z2
Entrez Gene ID: (Human) 31, (Human) 32, (Mouse) 107476, (Rat) 60581, (Rat) 116719, (Mouse) 100705
If an Invitrogen™ antibody doesn't perform as described on our website or datasheet,we'll replace the product at no cost to you, or provide you with a credit for a future purchase.*
Learn more
Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.
Contact tech support